When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352–63.
Moore DJ, Pasipanodya EC, Umlauf A, Rooney AS, Gouaux B, Depp CA, et al. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: a pilot randomized clinical trial. Drug Alcohol Depend. 2018;189:154–60.
Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS and behavior. 2007;11(2):185–94.
Parsons JT, Kowalczyk WJ, Botsko M, Tomassilli J, Golub SA. Aggregate versus day level association between methamphetamine ise and HIV medication non-adherence among gay and bisexual men. AIDS and behavior. 2013;17(4):1478–87.
Shoptaw S, Reback CJ. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 2006;83(6):1151–7.
Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK. Grant I; Hnrc Group And The Tmarc Group. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012;24(12):1504–13.
Perron BE, Mowbray OP, Glass JE, Delva J, Vaughn MG, Howard MO. Differences in service utilization and barriers among Blacks, Hispanics, and Whites with drug use disorders. Substance abuse treatment, prevention, and policy. 2009;4:3.
Chu C, Selwyn PA. Current health disparities in HIV/AIDS. The AIDS reader. 2008;18(3):144 -6, 52-8, c3.
Wohl A, Frye D, Johnson D. Demographic characteristics and sexual behaviors associated with methamphetamine use among MSM and non-MSM diagnosed with AIDS in Los Angeles County. AIDS Behav. 2008;12:705–12.
Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR, Remien RH, Rosen MI, Bangsberg DR, Liu H. Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012;60(5):466–72.
Friedman MR, Stall R, Silvestre AJ, Wei C, Shoptaw S, Herrick A, Surkan PJ, Teplin L, Plankey MW. Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015;29(9):1087–96.
Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, Golin CE, Bangsberg DR, Liu H. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013:142–7.
Singer M, Clair S. Syndemics and public health: reconceptualizing disease in a bio-social context. Med Anthropol Quart. 2003;17:423–41.
Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–57.
Nahum-Shani I, Hekler EB, Spruijt-Metz D. Building health behavior models to guide the development of just-in-time adaptive interventions: a pragmatic framework. Health Psychol. 2015;34(s):1209–19.
Pew Research Center. Mobile fact sheet http://www.pewinternet.org/fact-sheet/mobile/2018.
Catalani C, Philbrick W, Fraser H, Mechael P, Israelski DM. mHealth for HIV treatment & prevention: a systematic review of the literature. The open AIDS journal. 2013;7:17–41.
Donker T, Petrie K, Proudfoot J, Clarke J, Birch MR, Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res. 2013;15(11):e247.
Ashford RD, Lynch K, Curtis B. Technology and social media use among patients enrolled in outpatient addiction treatment programs: cross-sectional survey study. J Med Internet Res. 2018;20(3):e84.
Curtis BL, Ashford RD, Magnuson KI, Ryan-Pettes SR. Comparison of smartphone ownership, social media use, and willingness to use digital interventions between generation Z and millennials in the treatment of substance use: cross-aectional questionnaire study. J Med Internet Res. 2019;21(4):e13050.
Nebeker C, Linares-Orozco R, Crist K. A multi-case study of research using mobile imaging, sensing and tracking technologies to objectively measure behavior: ethical issues and insights to guide responsible research practice. Journal of Research Administration. 2015;46(1):118–37.
Matson M, Macapagal K, Kraus A, Coventry R, Bettin E, Fisher CB, et al. Sexual and gender minority youth’s perspectives on sharing de-identified data in sexual health and HIV prevention research. Sexuality Research and Social Policy. 2019;16(1):1–11.
Abadie R, Goldenberg S, Welch-Lazoritz M, Fisher CB. Establishing trust in HIV/HCV research among people who inject drugs (PWID): insights from empirical research. PloS one. 2018;13(12):e0208410.
Grov C, Rendina HJ, John SA, Parsons JT. Determining the roles that club drugs, marijuana, and heavy drinking play in PrEP medication adherence among gay and bisexual men: implications for treatment and research. AIDS and behavior. 2019;23(5):1277–86.
Nebeker C, Lagare T, Takemoto M, Lewars B, Crist K, Bloss CS, et al. Engaging research participants to inform the ethical conduct of mobile imaging, pervasive sensing, and location tracking research. Transl Behav Med. 2016;6(4):577–86.
Atienza AA, Zarcadoolas C, Vaughon W, Hughes P, Patel V, Chou WY, et al. Consumer attitudes and perceptions on mHealth privacy and security: findings from a mixed-methods study. Journal of health communication. 2015;20(6):673–9.
Miller CW, Himelhoch S. Acceptability of mobile phone technology for medication adherence interventions among HIV-positive patients at an urban clinic. AIDS research and treatment. 2013;2013:670525.
Rendina HJ, Millar BM, Parsons JT. Situational HIV stigma and stimulant use: a day-level autoregressive cross-lagged path model among HIV-positive gay and bisexual men. Addict Behav. 2018;83:109–15.
Grady C. Do IRBs protect human research participants? JAMA. 2010;304(10):1122–3.
Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006;18(7):853–61.
Skinner HA. The drug abuse screening test. Addictive Behaviors. 1982;7(4):363–71.
Rollnick S, Heather N, Gold R, Hall W. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. British journal of addiction. 1992;87(5):743–54.
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. The American psychologist. 1992;47(9):1102-34.
Morse J. Qualitative Health Research. Thousand Oaks, CA: Sage; 2002.
Strauss A. A qualitative analysis for social scientists. New York, NY: Cambridge University Press; 1988.
Software V. MAXQDA 12.3.1 ed. Verbi Software: Berlin, Germany; 2017.
Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3 Epub 2005/05/11.
Balfour L, Corace K, Tasca GA, Tremblay C, Routy JP, Angel JB. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173). AIDS care. 2010;22(11):1403–9.
Dube K, Taylor J, Sylla L, Evans D, Dee L, Burton A, Willenberg L, Rennie S, Skinner A, Tucker JD, Weiner BJ. 'Well, it's the risk of the unknown… right?': a qualitative study of perceived risks and benefits of HIV cure research in the United States. PLoS One. 2017;12(1):e0170112.
Henderson GE, Peay HL, Kroon E, et al. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics. 2018;44:270–6.
Arnold MP, Evans D, Vergel N. Recruitment and ethical considerations in HIV cure trials requiring treatment interruption. J Virus Erad. 2015;1:43–8.
Montoya JL, Georges S, Poquette A, Depp CA, Atkinson JH, Moore DJ. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014;26(12):1477–81.
Rendina HJ, Mustanski B. Privacy, trust, and data sharing in web-based and mobile research: participant perspectives in a large nationwide sample of men who have sex with men in the United States. J Med Internet Res. 2018;20(7):e233.
Hood JE, Buskin SE, Golden MR, Glick SN, Banta-Green C, Dombrowski JC. The changing burden of HIV attributable to methamphetamine among men who have sex with men in King County, Washington. AIDS patient care and STDs. 2018;32(6):223-.
Das-Douglas M, Colfax G, Moss AR, Bangsberg DR, Hahn JA. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003. J Urban Health. 2008;85(2):239–49.
Ben-Zeev D, Schueller SM, Begale M, Duffecy J, Kane JM, Mohr DC. Strategies for mHealth research: lessons from 3 mobile intervention studies. Adm Policy Ment Health. 2015;42(2):157–67.
Lifeline Program for Low-Income Consumers. Federal Communications Commission website. Updated 12/18/2019. Accessed 1/3/2020. Available from: https://www.fcc.gov/general/lifeline-program-low-income-consumers.
Pham Q, Wiljer D, Cafazzo JA. Beyond the Randomized controlled trial: a review of alternatives in mHealth clinical trial methods. JMIR Mhealth Uhealth. 2016;4(3):e107.
Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30(1):65–73.
Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21–48.
Klasnja P, Hekler EB, Shiffman S, Boruvka A, Almirall D, Tewari A, Murphy SA. Microrandomized trials: an experimental design for developing just-in-time adaptive interventions. Health Psychol. 2015;34(Suppl):1220–8.
Protogerou C, Johnson BT. Factors underlying the success of behavioral HIV-prevention interventions for adolescents: a meta-review. AIDS and behavior. 2014;18(10):1847–63.